Introduction: Urine cytology (UC) is a recommended tool for the diagnosis of urothelial malignancies. Thus far, no specific recommendations regarding the role of washing cytology (WC) have been included in the guidelines. The goal of our study was to analyse the relationship between the histology of transurethrally (transurethral resection of the bladder [TURBT]) resected bladder tumours (BCa) and intraoperative UC or WC findings. Materials and Methods: Five hundred consecutive primary TURBT cases conducted between November 2010 and 2015 at our department of the University Hospital Luebeck were retrospectively analysed. Sensitivity, specificity, positive (PPV) and negative predictive values (NPV) of UC and WC were evaluated to detect BCa. Multivariate logistic regression models were fit to further examine associations between patient- and tumour-related factors and a bladder UC or WC positive for BCa. Results: UC was performed in 297 patients, WC in 294 patients, and both in 261 patients. Sensitivity was 50.7% in UC, 58.1% in WC, and 62.1% for both tests combined. Specificity was 97.8% for UC, 98.0% for WC, and 96.4% for the combined tests. PPV was 98.0% for UC, 98.1% for WC, and 97.2% for combined tests. NPV was 47.8% for UC, 54.5% for WC, and 55.9% for the combined tests. The multivariate analyses revealed no association between positive UC or WC results and subsequent radical cystectomy (UC OR 1.35, 95% CI: 0.3–5.7; WC OR 2.0, 95% CI: 0.4–11.4). Neither UC nor WC was significantly correlated with local recurrence. Conclusions: Cytologic testing is an important diagnostic tool in BCa detection, showing acceptable sensitivity of around 60% and excellent specificity of over 90%. UC and WC present similar sensitivity. Our results advocate, however, against cytologic testing during primary TURBT, especially with regard to the lack of value in assessing the risk of recurrence. The clinical benefit of taking both types of samples at once is minimal. Furthermore, intraoperative WC collection does not reliably predict subsequent cystectomies.

1.
Kamat
AM
,
Hahn
NM
,
Efstathiou
JA
,
Lerner
SP
,
Malmström
P-U
,
Choi
W
.
Bladder cancer
.
Lancet
.
2016 03
388
10061
2796
810
.
2.
Luo
Y
,
She
D-L
,
Xiong
H
,
Yang
L
,
Fu
S-J
.
Diagnostic value of liquid-based cytology in urothelial carcinoma diagnosis: a systematic review and meta-analysis
.
PLoS One
.
2015 Aug
10
8
e0134940
.
3.
Rathert
P
,
Roth
S
,
Hakenberg
O
,
Neuendorf
J
, editors.
Urinzytologie und Sedimentanalyse
5th ed.
Berlin
Springer
2018
4.
Cakir
E
,
Kucuk
U
,
Pala
EE
,
Sezer
O
,
Ekin
RG
,
Cakmak
O
.
Cytopathologic differential diagnosis of low-grade urothelial carcinoma and reactive urothelial proliferation in bladder washings: a logistic regression analysis
.
APMIS
.
2017 May
125
5
431
6
.
5.
Barkan
GA
,
Wojcik
EM
,
Nayar
R
,
Savic-Prince
S
,
Quek
ML
,
Kurtycz
DFI
.
The Paris system for reporting urinary cytology: the quest to develop a standardized terminology
.
Acta Cytol
.
2016
;
60
(
3
):
185
97
.
6.
Kuan
KC
,
Segura
SE
,
Ahlstedt
J
,
Khader
SN
,
Hakima
L
.
The predictive value of positive and suspicious urine cytology: are they different
.
Diagn Cytopathol
.
2020 Nov
48
11
998
1002
.
7.
Raitanen
M-P
,
Aine
R
,
Rintala
E
,
Kallio
J
,
Rajala
P
,
Juusela
H
.
Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis
.
Eur Urol
.
2002 Mar
41
3
284
9
.
8.
Yafi
FA
,
Brimo
F
,
Steinberg
J
,
Aprikian
AG
,
Tanguay
S
,
Kassouf
W
.
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
.
Urol Oncol
.
2015 Feb
33
2
66.e25
31
.
9.
AWMF
. S3-Leitlinie Harnblasenkarzinom Langversion 2.0. [cited 2022 Sep 24]. Available from: https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Blasenkarzinom/Version_2.0/LL_Harnblasenkarzinom_Langversion_2.0.pdf.
10.
Alfred Witjes
J
,
Lebret
T
,
Compérat
EM
,
Cowan
NC
,
De Santis
M
,
Bruins
HM
.
Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer
.
Eur Urol
.
2017
;
71
(
3
):
462
75
.
11.
Abro
S
,
Nomani
L
,
Wojcik
EM
,
Pambuccian
SE
,
Chatt
G
,
Barkan
GA
.
Outcome analysis and negative predictive value of the “unsatisfactory/nondiagnostic” category of the Paris System for Reporting Urinary Cytology
.
J Am Soc Cytopathol
.
2021 Feb
10
1
64
70
.
12.
GOÄ – Gebührenordnung für Ärzte. [cited 2022 Oct 24]. Available from: http://www.gesetze-im-internet.de/go__1982/BJNR015220982.html
13.
Statistisches Bundesamt
Fallpauschalenbezogene Krankenhausstatistik (DRG-Statistik) Operationen und Prozeduren der vollstationären Patientinnen und Patienten in Krankenhäusern (4-Steller) - 2020
. 2020 [cited 2022 Oct 5]. Available from: https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Gesundheit/Krankenhaeuser/Publikationen/Downloads-Krankenhaeuser/operationen-prozeduren-5231401207014.pdf?__blob=publicationFile.
14.
Jancke
G
,
Rosell
J
,
Chebil
G
,
Jahnson
S
.
Bladder wash cytology at diagnosis of Ta-T1 bladder cancer is predictive for recurrence and progression
.
Urology
.
2012 Sep
80
3
625
31
.
15.
Vom Dorp
F
,
Pal
P
,
Tschirdewahn
S
,
Rossi
R
,
Börgermann
C
,
Schenck
M
.
Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tract
.
Urol Int
.
2011
;
86
(
1
):
36
40
.
16.
Garbar
C
,
Mascaux
C
,
Wespes
E
.
Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses
.
Cytopathology
.
2007 Apr
18
2
79
83
.
17.
Schmitz-Dräger
BJ
,
Droller
M
,
Lokeshwar
VB
,
Lotan
Y
,
Hudson
MA
,
van Rhijn
BW
.
Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus
.
Urol Int
.
2015
;
94
(
1
):
1
24
.
18.
Karakiewicz
PI
,
Benayoun
S
,
Zippe
C
,
Lüdecke
G
,
Boman
H
,
Sanchez-Carbayo
M
.
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder
.
BJU Int
.
2006 May
97
5
997
1001
.
19.
Planz
B
,
Jochims
E
,
Deix
T
,
Caspers
HP
,
Jakse
G
,
Boecking
A
.
The role of urinary cytology for detection of bladder cancer
.
Eur J Surg Oncol
.
2005 Apr
31
3
304
8
.
20.
Suh
J
,
Go
H
,
Sung
C
,
Baek
S
,
Hwang
H
,
Jeong
S
.
Modification of the Paris System for urinary tract washing specimens using diagnostic cytological features
.
Cytopathology
.
2017 Dec
28
6
516
23
.
21.
Kumar
NU
,
Dey
P
,
Mondal
AK
,
Singh
SK
,
Vohra
H
.
DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma
.
Diagn Cytopathol
.
2001 Mar
24
3
153
6
.
22.
Bakhos
R
,
Shankey
TV
,
Flanigan
RC
,
Fisher
S
,
Wojcik
EM
.
Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases
.
Diagn Cytopathol
.
2000 Feb
22
2
65
9
.
23.
Keller
AK
,
Jensen
JB
.
Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better
.
Scand J Urol
.
2017 Aug
51
4
290
2
.
24.
Bansal
S
,
Pathuthara
S
,
Joseph
S
,
Dighe
S
,
Menon
S
,
Desai
SB
.
Is diagnosis of low-grade urothelial carcinoma possible in urine cytology
.
J Cytol
.
2021
;
38
(
2
):
64
8
.
25.
Whisnant
RE
,
Bastacky
SI
,
Ohori
NP
.
Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification
.
Diagn Cytopathol
.
2003 Apr
28
4
186
90
.
26.
Elsawy
AA
,
Harraz
AM
,
Ghobrial
FK
,
Abdullatef
M
,
Ali-El-Dein
B
.
Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: a prospective study
.
Urol Oncol
.
2020 Dec
38
12
935.e1
8
.
27.
Lodde
M
,
Mayr
R
,
Martini
T
,
Comploj
E
,
Palermo
S
,
Trenti
E
.
Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy
.
World J Urol
.
2012 Dec
30
6
841
6
.
You do not currently have access to this content.